Sarah E Leary
Pediatric Brain Tumor Consortium · Children's Oncology Group
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sarah E Leary as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:54 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00867178 · Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous SystemNational Cancer Institute (NCI) · completed · Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified · principal investigator
- Ph3NCT00392327 · Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNETChildren's Oncology Group · completed · Anaplastic Medulloblastoma, Medulloblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trialsR50CA275857 · NCI · SEATTLE CHILDREN'S HOSPITAL · fiscal years 2023 to 2026 · $175,338 awarded in 2026Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Pediatric Brain Tumor Consortium (PBTC)U01CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI JAMES Milford BOYETT · fiscal years 1999 to 2013Named on NCT00867178
- Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumorsUM1CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Ira J Dunkel, Arzu Onar-Thomas · fiscal years 2014 to 2026Named on NCT00867178
- Targeted Therapy in Ex Vivo MedulloblastomaR01CA114567 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI JAMES M OLSON · fiscal years 2006 to 2023Named on NCT00392327
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT00392327
- COG NCTN Network Group Operations CenterU10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026Named on NCT00392327
Most cited trial papers
Clinical-trial papers with this author name in medulloblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:54 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.JAMA Oncol · 2021130 citationsRCR 7.6
- Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).Neuro Oncol · 202233 citationsRCR 2.4
- Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.Neuro Oncol · 202523 citationsRCR 6.7